NewAmsterdam Pharma Company NV Ordinary Shares
Price & Volume
Stats
See more52W Range | $14.06-$28.61 |
Market Cap | $2.9B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $64M |
Revenue Growth (YoY) | 740.1% |
Gross Profit (12 Mos) | $64M |
Diluted EPS | -$1.59 |
News
See moreYahoo Finance • 2 months ago
NewAmsterdam Pharma reports Q2 results
Yahoo Finance • 2 months ago
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
Yahoo Finance • 2 months ago
Obicetrapib shows promise in reducing Alzheimer's biomarkers
About
CEO | Dr. Michael Harvey Davidson FACC, Facp., M.D. |
Address | Gooimeer 2-35, Naarden, Netherlands, 1411 DC |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |
